FIRMQUARRYResearch workspace

FIRMQUARRY / COMPANY INTELLIGENCE

['Merck Sharp & Dohme s.r.o.', 'Takeda Pharmaceuticals Czech Republic s.r.o.']

Not reported · Verified headquarters unavailable

Track with Pro
Data last updated Oct 22, 2026 · Source: official procurement and company-intelligence sources

General information

Legal name
['Merck Sharp & Dohme s.r.o.', 'Takeda Pharmaceuticals Czech Republic s.r.o.']
First / latest observed
Nov 3, 2026 — Nov 3, 2026

One source-backed chronology

Timeline

Business change, facilities, workforce, corporate events, and government activity appear chronologically.

  1. Government
    Award announced

    Antivirotika pro systémové použití – CMV – Letermovir, Maribavir II.

    EU_TED · Tenders Electronic DailyCZK 18,900,000source backed · match auto verifiedcollected Nov 3, 2026Official source ↗

Disclosed procurement context

Government Business

Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.

Global government business

Markets and currencies remain separate; incompatible currencies are never summed.

MarketDisclosed valueCurrencyLatest activityProcesses
CZECZK 18.9MCZKNov 2, 20261

Evidence and identifiers

Sources & Coverage

Technical identifiers live here, with retained official links and visible coverage limitations.

Platform coverage →

Source identifiers

  • OCDS_PARTYeu_ted:36fa6069-67fb-4c81-bb28-0173d8c4a113:65998453-9880-44ce-a6b9-6161ca4cee5b:0 · source ↗